He looked at insurance claims data in a research letter published in JAMA and found that few patients actually adhere to the drugs for the long term
Patients will be excluded (1) if they have had a heart attack, stroke, hospitalization for congestive heart failure or unstable angina within 90 days before screening, (2) if they have been taking any weight loss drugs, including over-the-counter medications, within 90 days before screening, (3) if they have had a change in body weight greater than 11 pounds within 90 days, (4) if they have or are planning a surgical treatment for excess weight, (5) if they have Type 1 Diabetes Mellitus, (6) if they have a family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN-2) and (7) if they have had pancreatitis
Eli Lillys Lilly Cares program covers Mounjaro and Zepbound for patients at or below 300% of the federal poverty level
Food Demand in a Post-Ozempic World. CHOICES Magazine
In the head-to-head SURPASS-2 trial (NEJM 2021), tirzepatide 15 mg beat semaglutide 1 mg on HbA1c (2.30% vs 1.86%) and weight loss (11.2 kg vs 5.7 kg)